Latest News in the pharma Industry

Top Stories

Lilly & ImmunoGen Form Antibody-drug Conjugate Collaboration

Lilly & ImmunoGen Form Antibody-drug Conjugate Collaboration

21 Dec 2011

Lilly will use ImmunoGen's maytansinoid Targeted Antibody Payload technology with Lilly monoclonal antibodies to develop novel ADC anticancer therapeutics.

Read more 
Arecor Forms Collaboration with Lilly

Arecor Forms Collaboration with Lilly

21 Dec 2011

Arecor will develop stable aqueous or higher concentration formulations of emerging protein and peptide drug candidates developed by Lilly.

Read more 
Report Focuses on VC Investments of Life Science Companies

Report Focuses on VC Investments of Life Science Companies

21 Dec 2011

Biotechnology and pharmaceuticals were the top areas for investment, with around 30% going to each area. The therapeutic areas of oncology, neurology and infectious diseases saw the most investment.

Read more 
Pall Corp. to Acquire ForteBio

Pall Corp. to Acquire ForteBio

20 Dec 2011

The transaction is expected to close by February of 2012. ForteBio will become a wholly-owned subsidiary of Pall Corp.

Read more 
Amgen & Watson Sign for Oncology Biosimilars

Amgen & Watson Sign for Oncology Biosimilars

20 Dec 2011

Under the terms of the agreement, Amgen will assume primary responsibility for developing, manufacturing and initially commercializing the oncology antibody products.

Read more 
Pfizer & Glaxo Expand Supply Agreements for Pneumonia Vaccines

Pfizer & Glaxo Expand Supply Agreements for Pneumonia Vaccines

20 Dec 2011

Pfizer and GSK will supply hundreds of millions of additional doses of pneumonia vaccine to an international partnership for immunization to children in developing countries.

Read more 
Valeant Pharmaceuticals Proposes to Acquire ISTA

Valeant Pharmaceuticals Proposes to Acquire ISTA

19 Dec 2011

The proposed transaction has a total equity value of approximately $314 million on a fully diluted basis. In addition, ISTA has net debt of approximately $13 million, bringing the total enterprise value to approximately $327 million.

Read more 
Amgen CEO to Retire Next Year

Amgen CEO to Retire Next Year

19 Dec 2011

Mr. Sharer will step down as CEO effective May 23, 2012, and remain as chairman until December 31, 2012.

Read more 
Sygnature Extends Strategic Alliance with Cyprotex

Sygnature Extends Strategic Alliance with Cyprotex

19 Dec 2011

The two firms have signed an extension of their strategic alliance for a further two years to accelerate their clients’ drug discovery projects into development.

Read more 
UK Cancer Treatment Costs to Soar over Next Decade

UK Cancer Treatment Costs to Soar over Next Decade

16 Dec 2011

A new report says the costs associated with the diagnosis and treatment of cancer in the UK will dramatically increase by 2021.

Read more 
EMA Confirms Positive Benefit-risk Balance of Somatropin-Containing Medicines

EMA Confirms Positive Benefit-risk Balance of Somatropin-Containing Medicines

16 Dec 2011

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) confirms that the benefit-risk balance of somatropin-containing medicines remains positive.

Read more 
Enlight Teams up with AZ and Novo

Enlight Teams up with AZ and Novo

16 Dec 2011

Enlight Biosciences has formed new partnerships with UK-based AstraZeneca and Denmark-based Novo Nordisk for the development of potentially transformational technologies.

Read more